Could a famous drug, often prescribed for entirely different purposes, hold the key to improving heart health in diabetics? New evidence suggests that this well-established medication may considerably reduce cardiovascular risk in people with diabetes, even those without symptoms of heart disease.
Heart problems are a real concern for millions of people with diabetes. While conventional medicine has long focused on lowering blood sugar, blood pressure, and cholesterol levels, new research raises the possibility of an additional, less well-known protective strategy. Researchers studied how this long-used drug may also reduce inflammation, a major cause of heart disease. Their research provides new evidence that reducing inflammation may be the key to protecting diabetic hearts from complications. Additionally, this medication’s low cost and widespread availability pave the way for more accessible and effective preventative treatment.
Experts warn that more study is required before this therapy is considered routine, despite the promising outcomes. However, the ramifications are significant: this cheap and easy intervention could potentially save millions of lives from cardiovascular disease. Read the full article to learn more about the research, its potential benefits, and its future implications for diabetes treatment. This page has contributions from Dr. Mary Greene, who works at Manhattan Cardiology. Read the article.
Would you like to make an appointment with Dr. Mary Greene?
